Document:

ex10-13.htm

    GAMMA
PHARMACEUTICALS INC.

    

    SECURITIES PURCHASE
AGREEMENT

    

    

    THIS
SECURITIES PURCHASE AGREEMENT (as amended, modified, supplemented or restated in
accordance with its terms from time to time, this “Agreement” or “SPA”) is
between GAMMA PHARMACEUTICALS INC., a Delaware corporation and its affiliates
(the “Company”), and KENRIDGE
HOLDINGS LLC (the “Purchaser”).

     

    RECITALS

    

    WHEREAS,
the Company has authorized the offering and sale of up to 1,333,333 (One Million
Three Hundred Thirty Three Thousand Three Hundred Thirty Three) common
restricted unencumbered shares. Additionally, Purchaser shall have the right to
purchase 1,333,333 in Warrant A at $0.75; 1,333,333 in Warrant B at $1.00; and
1,333,333 in Warrant C at $1.25. These Warrants all shall have a five year
exercise right.

    

    WHEREAS,
The Purchaser has placed, through Escrow to the Company, One Million Dollars US
(One Million USD) as consideration for the Securities purchased
hereunder

    

    WHEREAS,
the Company has the right to terminate the Offering early with a 15-day prior
written notice to the Purchaser (“Early Termination Date”).  In the
event a Closing has already occurred, this early termination will not relieve
the Company of any other of its obligations contained in the Offering with
respect to such closing; and

    

    WHEREAS,
the Shares will be offered and sold only to “accredited investors” within the
meaning of Rule 501(a) of Regulation D promulgated under the Securities Act
pursuant to this Agreement and that certain subscription agreement executed by
the Purchasers in connection with the Offering (the “Subscription Agreement”);
and

    

    WHEREAS,
each Common UNIT consists of One Share of Common Stock and One Series A Investor
Warrant, One Series B Investor Warrant, and One Series C Investor Warrant. The
Warrants mentioned supra shall have the specified strike price: A, $0.75 each; B
$1.00 each, and C, $1.25., and all Warrants shall have a five year exercise
right

    

    WHEREAS,
Purchasers desire to purchase the Shares on the terms and conditions set forth
herein and in the Subscription Agreement; and

    

    WHEREAS,
the Company desires to sell the Shares to Purchasers on the terms and conditions
set forth herein.

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    AGREEMENT

    

    In
consideration of the recitals and the mutual promises, covenants and agreements
contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto hereby agree as
follows:

    

    ARTICLE  I

    

    AUTHORIZATION AND
SALE OF THE
SHARES

    

    1.1 Authorization. The
Company has, prior to the date of this Agreement, (i) authorized the issuance
and sale of the Shares to the Purchasers and (ii) authorized issuance of and
reserved for issuance shares upon warrant exercise.

    

    1.2 Sale of the Shares to the
Purchasers. Subject in all respects to the satisfaction of the terms and
conditions herein set forth, and in reliance upon the respective representations
and warranties of the parties set forth herein, in this SPA and in any document
delivered pursuant hereto or thereto, the Company agrees to sell to each
Purchaser (and such Purchaser agrees by executing and delivering the Execution
Documents and investment amount to purchase from the Company) the number of
Shares set forth in such Purchasers’ Subscription Agreement at the Offering
Price.

    

    1.3 Offering Price and Share
Calculation. Each Share shall be priced at the $0.75 per share for a
total number of 1,333,333 shares.

    

    1.4 Delivery of the Shares to
the Purchasers. Upon the execution and delivery by the Purchasers of the
Execution Documents and the investment amount, the Company will calculate the
number of Shares purchased by the Purchaser and express said funds to the Escrow
Agent.  The Shares will be issued to the Purchaser when the
subscription has been accepted by the Company and the Company receives notice
that the funds have been cleared by the bank holding the funds.  This
delivery in no way shall exceed 10 days from the Final Closing or Early
Termination date whichever is first.

    

    1.5 Early
Termination.  Notwithstanding anything contained herein to the
contrary, the Company has the right to terminate the Offering at any time upon
15 days’ written notice to Placement Agent (“Early Termination
Date”).  In the event a Closing has already occurred, this early
termination will not relieve the Company of its obligations to register the
Shares and shares of Common Stock underlying the Warrant (the “Warrant Shares”)
sold at such Closing.

    

    1.6           Terms of
Warrant.  (a) The Warrants mentioned supra shall have the
specified strike price: A, $0.75 each; B $1.00 each, and C, $1.25., which shall
have a five year exercise right. The Warrants will be issued in unregistered
form.

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (b)           The
Warrant Shares, when issued upon exercise of a Warrant, will

    be fully
paid and non-assessable, and the Warrant Shares will be registered in the
Registration Statement mentioned elsewhere in this agreement. Company will pay
any transfer tax incurred as a result of the issuance of Common Stock to the
holder upon its exercise.

    

    ARTICLE
II

    

    REGISTRATION
RIGHTS

    

    2.1 Registration of Shares by
Company. The Investor will receive “piggy back” registration rights
and will be included on the Company’s next registration statement covering the
Shares and Warrant Shares (the “Registration Statement”). Purchaser shall have
the right to require company to register said shares after six months from date
of sale.

    

    
      	
               
      

            	
              ARTICLE
      III

            

    

    

    REPRESENTATIONS AND
WARRANTIES OF THE COMPANY

    

    The
Company represents and warrants (such representations and warranties do not
lessen or obviate the representations and warranties of the Purchasers set forth
in this Agreement or the Subscription Agreement) that:

    

    3.1 Organization and Existence,
Authority, Etc. The Company is a corporation duly organized and validly
existing and in good standing under the laws of the State of Nevada, and has all
requisite corporate power and authority to carry on its business as now
conducted and proposed to be conducted; the Company has all requisite corporate
power and authority to enter into this Agreement, to issue the Shares as
contemplated herein and to carry out the provisions and conditions of this
Agreement. This Agreement has been duly executed and delivered by, and
constitutes the valid and binding obligations of, the Company, enforceable in
accordance with their respective terms, subject to the effect of any applicable
bankruptcy, moratorium, insolvency, reorganization or other similar law
affecting the enforceability of creditors' rights generally and to the effect of
general principles of equity which may limit the availability of remedies
(whether in a proceeding at law or in equity). The Company is duly qualified and
is authorized to do business and is in good standing as a foreign corporation in
each jurisdiction in which the conduct of its business or ownership of its
properties would so require, except where the failure to be so qualified would
not have a material adverse effect on its business and financial condition,
taken as a whole.  The Company will preserve, protect, and maintain,
(a) its corporate existence, and (b) all rights, franchises, accreditations,
privileges, and properties, the failure of which to preserve, protect, and
maintain might have a material adverse effect on the business, affairs, assets,
prospects, operations, employee relations, rights or condition, financial or
otherwise, of the Company taken as a whole.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    3.2 Litigation. Except as
disclosed in the Company Commission Filings (as hereinafter defined) and the
Private Placement Memorandum, to the knowledge of the Company, there is no
action, suit or proceeding pending, or threatened, against the Company before
any court, administrative agency or arbitrator which could reasonably be
expected to result in any material adverse change in the business, properties,
condition (financial or otherwise) of the Company, taken as a whole, or which
challenges the validity of any action taken or to be taken pursuant to or in
connection with this Agreement.

    

    3.3 Charter Documents.
Neither the execution nor the delivery of this Agreement, nor the consummation
of the transactions contemplated hereby, nor compliance with the terms and
provisions hereof, will conflict with, or result in a breach of or creation of a
lien under, the terms, conditions or provisions of, or constitute a default
under, the charter or by-laws of the Company, as amended, copies of which are
available to the Purchasers in the Company Commission Filings.

    

    3.4 Authorized and Outstanding
Capital Stock. As of February 13th, 2008,
there are outstanding and issued approximately 15,603,635 shares of Common
Stock. All of such outstanding shares of Common Stock have been validly issued
and are fully paid and non-assessable. The Company has authorized the issuance
of the number of Shares and Warrant Shares deliverable to the Purchasers under
this Offering calculated at the Offering Price, up to $1,000,000. The Shares
when issued as part of the Shares in accordance with the terms of this Agreement
will be validly issued, fully paid and non-assessable.

    

    3.5 Commission Filings and
Financial Statements. True and complete copies of all reports,
registration statements, definitive proxy statements and other documents (in
each case together with all amendments and supplements thereto) filed by the
Company with the Securities and Exchange Commission (such reports, registration
statements, definitive proxy statements and other documents, together with any
amendments and supplements thereto, are sometimes collectively referred to as
the "Company Commission Filings") are available to the Purchasers at the
Commission’s website www.sec.gov. The Company Commission Filings constitute all
of the documents (other than preliminary materials) that the Company was
required to file with the Commission. As of their respective dates, each of the
Company Commission Filings complied in all material respects with the applicable
requirements of the Securities Act and the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), as applicable, and the rules and regulations under
each such act, and none of the Company Commission Filings contained as of such
date any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading. When
filed with the Commission the financial statements included in the Company
Commission Filings complied as to form in all material respects with the
applicable rules and regulations of the Commission and were prepared in
accordance with generally accepted accounting principles (as in effect from time
to time) applied on a consistent basis (except as may be

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    indicated
therein or in the notes or schedules thereto), and such financial statements
fairly present in accordance with generally accepted accounting principles in
all material respects the financial position of the Company as at the dates
thereof and the results of its operations and its cash flows for the periods
then ended, subject, in the case of the unaudited interim financial statements,
to normal, recurring year-end audit adjustments and the absence of
footnotes.

    

    3.6 Intellectual
Property. The Company shall maintain in full force and affect its
corporate existence, rights and franchises and all licenses and other rights to
use Intellectual Property owned or possessed by it and reasonably deemed to be
necessary to the conduct of its business.

    

    

    3.7 Tax Returns and
Payments. The Company has timely filed all tax returns (federal, state
and local) required to be filed by it. All taxes shown to be due and payable on
such returns, any assessments imposed, and to the Company's knowledge all other
taxes due and payable by the Company as of the date hereof, have been paid, are
being contested in good faith or will be paid prior to the time they become
delinquent. The Company has not been advised (a) that any of its returns,
federal, state or other, have been or are being audited as of the date hereof,
or (b) of any deficiency in assessment or proposed judgment to its federal,
state or other taxes. The Company has no knowledge of any liability of any tax
to be imposed upon its properties or assets as of the date of this Agreement
that is not adequately provided for.

    

    

    3.8 Title to Properties.
The Company has good and marketable title to its properties and assets, and good
title to its leasehold estates, in each case subject to no mortgage, pledge,
lien, lease, encumbrance or charge, other than (a) those resulting from taxes
which have not yet become delinquent, (b) minor liens and encumbrances which do
not materially detract from the value of the property subject thereto or
materially impair the operations of the Company, and (c) those that have
otherwise arisen in the ordinary course of business. The Company is in
compliance with all material terms of each lease to which it is a party or is
otherwise bound.

    

    3.9 Compliance with Other
Instruments, Etc. The Company is not in violation of any term of its
certificate or articles of incorporation or by-laws, and the Company is not in
material violation of any material term of any material agreement or instrument
to which it is a party or by which it is bound or any material term of any
applicable law, ordinance, rule or regulation of any governmental authority or
any material term of any applicable order, judgment or decree of any court,
arbitrator or governmental authority, the consequences of which violation might
have a materially adverse effect on the business, condition (financial or
other), operations, assets or properties of the Company; the execution, delivery
and performance of this Agreement and the Related Agreements will not result in
any material violation of or be in material conflict with or constitute a
material default under any such term; and there is no such term which
materially

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    adversely
affects the business, condition (financial or other), operations, assets, or
properties of the Company, taken as a whole.

    

    3.10
Governmental
Consent. No material consent, approval or authorization of, or
declaration or filing with, any governmental authority on the part of the
Company or any of its Subsidiaries is required for the valid execution and
delivery of this Agreement and the Related Agreements or the valid offer, issue,
sale and delivery of the Shares pursuant to this Agreement or the Related
Agreements, except where the failure to obtain such consent or make such filing
would not have a material adverse effect on the business, operations or assets
of the Company, and except for appropriate filings (i) with the Commission and
(ii) with such state securities commissions in respect of "blue sky" laws as may
be appropriate.

    

    3.11
Use of
Proceeds. The Company and management will have full discretion on the use
the proceeds which may include but not limited to general working
capital.

    

    3.12                      Disclosure. To the
best of the Company's knowledge, there is no fact (other than matters of a
general economic or political nature which does not affect the Company uniquely)
known to the Company which materially adversely affects the business, condition
(financial or other), operations, assets or properties of the Company which has
not been set forth either in the Company Commission Filings or in this Agreement
or in the other documents, certificates and instruments delivered to the
Purchasers by or on behalf of the Company specifically for use in connection
with the transactions contemplated by this Agreement.

    

    

    ARTICLE
IV

    

    REPRESENTATIONS AND
WARRANTIES OF THE PURCHASERS

    

    Each
Purchaser hereby severally and not jointly represents and warrants to the
Company with respect to itself or himself as follows (such representations and
warranties do not lessen or obviate the representations and warranties of the
Company set forth in this Agreement):

    

    4.1 Requisite Power and
Authority. Purchaser has all necessary power and authority under all
applicable governing documents and provisions of law to execute and deliver this
Agreement and the Related Agreements and to carry out their provisions. All
action on Purchaser's part required for the lawful execution and delivery of
this Agreement and the Related Agreements have been or will be taken prior to
the Closing Date. Upon their execution and delivery, this Agreement and the
Related Agreements will be valid and binding obligations of Purchaser,
enforceable in accordance with their terms, except (a) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium or other laws of general
application affecting enforcement of creditors' rights, and (b) as limited by
general principles of equity that restrict the availability of equitable
remedies.

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    4.2 Investment
Representations. Purchaser understands that the Shares are being offered
and sold pursuant to an exemption from registration contained in the Securities
Act based in part upon Purchaser's representations contained in the
Agreement.

    

    4.3 Purchaser Bears Economic
Risk. Purchaser has substantial experience in evaluating and investing in
private placement transactions of securities in companies similar to the Company
so that it is capable of evaluating the merits and risks of its investment in
the Company and has the capacity to protect its own interests. Purchaser must
bear the economic risk of this investment for an indefinite period of
time.

    

    4.4 Acquisition for Own
Account. Purchaser is acquiring the Shares for Purchaser's own account
for investment only, and not with a view towards their distribution or
resale.

    

    4.5 Purchaser Can Protect Its
Interest. Purchaser represents that by reason of his/her/its, or of its
management's, business or financial experience, Purchaser has the capacity to
protect its own interests in connection with the transactions contemplated in
this Agreement, and the Related Agreements. Further, Purchaser is aware of no
publication or any advertisement in connection with the transactions
contemplated in the Agreement.  In evaluating the suitability of an
investment in the Company, the Purchaser has not relied upon any representation
or other information (oral or written) other than as stated in this
Agreement.

    

    4.6 Self-Reliance. The
Purchaser is not relying on the Company or any of its employees or agents or
Placement Agent with respect to the legal, tax, economic and related
considerations as to an investment in the Securities, and the Purchaser has
relied on the advice of, or has consulted with, only his own
advisors

    

    4.7 Accredited Investor.
Each Purchaser acknowledges that a purchase of the Shares is only available to a
Purchaser who is an "accredited investor." In connection therewith, each
Purchaser represents and warrants to the Company and the Placement Agent that
he/she or it, as the case may be, qualifies as an "accredited investor" within
the meaning of Regulation D, since he/she or it meets one of the following
standards for determination of "accredited investor" status of Regulation D set
forth below:

    

    (a) Any
broker or dealer registered pursuant to Section 15 of the Exchange

    Act;

    

    (b) Any
natural person whose individual net worth, or joint net worth with

    that
person's spouse, at the time of his purchase exceeds $1,000,000;

    

    (c) Any
natural person who had an individual income in excess of $200,000 in each of the
two most recent years or joint income with that person's spouse in excess of
$300,000 in each of those years and has a reasonable expectation of reaching the
same income level in the current year;

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    

    (d) Any
trust, with total assets in excess of $5,000,000, not formed for the specific
purpose of acquiring the securities offered, whose purchase is directed by a
sophisticated person as described in Rule 506(b)(2)(ii) of Regulation
D;

    

    (e) Any
organization described in Section 501(c)(3) of the Internal Revenue Code of
1986, as amended, corporation, Massachusetts or similar business trust, or
partnership, not formed for the specific purpose of acquiring the securities
offered, with total assets in excess of $5,000,000; or

    

    (f) Any
entity in which all of the equity owners are "accredited
investors".

    

    4.8 Available
Information. Each Purchaser hereby represents that he/she/it (i) has
access to and has carefully reviewed the Company Commission Filings, and (ii)
has had the opportunity to ask questions and receive answers from the Company
concerning the Company Commission Filings and the terms and conditions of the
offering of the Shares and to obtain any documents relating to the Company which
are publicly available and any additional information or documents relating to
the Company which the Company possesses or can acquire without unreasonable
effort or expense.

    

    4.9  Regulatory
Compliance. Purchaser agrees that Purchaser will comply with
all

    relevant
rules and regulations of the Exchange Act, including the provisions of
Regulation M promulgated thereunder.

    

    4.10
Legends. Purchaser
understands that a portion of the certificates representing the components of
the Shares may bear the following legend (or one substantially similar) until
the Shares and Warrant Shares are covered by an effective registration statement
filed with the Commission:

    

    “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 AS AMENDED (THE "ACT") OR, IF APPLICABLE, STATE
SECURITIES LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM
THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
HYPOTHECATED, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A
CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT WITH RESPECT TO SUCH
SECURITIES, OR AN OPINION OF THE COMPANY'S COUNSEL TO THE EFFECT THAT
REGISTRATION IS NOT REQUIRED UNDER THE ACT. ALTHOUGH THE COMPANY HAS AN
OBLIGATION TO REGISTER FOR RESALE THE SHARES AND THE WARRANT SHARES, THERE CAN
BE NO ASSURANCE THAT SUCH REGISTRATION WILL BE COMPLETED WITHIN THE TIME FRAMES
REQUIRED, OR AT ALL.  THE SECURITIES HAVE NOT BEEN APPROVED OR
DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES
COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING
AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE
ACCURACY

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    OR
ADEQUACY OF THE INFORMATION CONTAINED. ANY REPRESENTATION TO THE CONTRARY IS
UNLAWFUL.”

    

    4.11
Confidentiality. The
Purchaser agrees that he/she/it will not include in any public announcement, the
name of the Company, unless expressly agreed to by the Company or unless and
until such disclosure is required by law or applicable regulation, and then only
to the extent of such requirement.

    

    4.12 Non-Manipulative
Practices. Under no circumstances is Placement Agent or Purchasers to
engage in any type of short selling in an attempt to hedge their positions or
manipulate the stock.

    

    4.13
Financial Position /
Requisite Knowledge.

    

    (a) That
the undersigned is in a financial position to hold the Securities for an
indefinite period of time and is able to bear the economic risk and withstand a
complete loss of the undersigned's investment in the Securities. Additionally,
the undersigned's proposed investment in the Securities does not exceed 20% of
the undersigned's net worth exclusive of home, home furnishings and
automobiles;

    

    (b) That
the undersigned, either alone or with the assistance of the undersigned's own
professional advisor, has such knowledge and experience in financial and
business matters that the undersigned is capable of evaluating the merits and
risks of an investment in the Securities, has the capacity to protect the
undersigned's own interests in connection with an investment in the Notes and
has the net worth to undertake such risks;

    

    (c) That
the undersigned has obtained, to the extent the undersigned deems necessary, the
undersigned's own personal professional advice with respect to the risks
inherent in the investment in the Securities, and the suitability of an
investment in the Securities in light of the undersigned's financial condition
and investment needs

    

    (d) That
the undersigned believes that an investment in the Securities is suitable for
the undersigned based upon their investment objectives and financial needs, and
the undersigned has adequate means for providing for the their current financial
needs and personal contingencies and has no need for liquidity of investment
with respect to the Securities;

    

    (e) That
the undersigned recognizes that the Securities as an investment involves a high
degree of risk, including, but not limited to, the risk of loss of 100% of the
undersigned's investment in the Securities;

    

    4.14
Purchaser Bears
Economic Risk. Purchaser has substantial experience in evaluating and
investing in private placement transactions of securities in companies similar
to the Company so that it is capable of evaluating the merits and risks of its
investment in the Company and has the capacity to protect its
own

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    interests.
Purchaser must bear the economic risk of this investment until the Securities
are registered pursuant to the Securities Act, or an exemption from registration
is available. That the undersigned realizes that (i) the purchase of the
Securities is a long-term investment; (ii) the purchaser of the Securities must
bear the economic risk of investment for an indefinite period of time because
the Securities have not been registered under the Act, or under the securities
laws of any state and, therefore, the Securities cannot be resold unless they
are subsequently registered under said laws or exemptions from such
registrations are available; (iii) there is presently no public market for the
Securities and the undersigned may be unable to liquidate the undersigned's
investment in the event of an emergency, or pledge the Securities as collateral
for a loan; and (iv) the transferability of the Securities is restricted and
requires conformity with the restrictions contained in Section 3.3 and legends
will be placed on the certificate(s) representing the Securities referring to
the applicable restrictions on transferability; and

    

    4.15
OFAC Statement.
The Purchaser should check the
Office of Foreign Assets Control (“OFAC”) website at
<http://www.treas.gov/ofac> before making the following
representations. The Purchaser represents that the amounts invested by it
in the Company in the Offering were not and are not directly or indirectly
derived from activities that contravene federal, state or international laws and
regulations, including anti-money laundering laws and regulations. Federal
regulations and Executive Orders administered by OFAC prohibit, among other
things, the engagement in transactions with, and the provision of services to,
certain foreign countries, territories, entities and individuals.  The
lists of OFAC prohibited countries, territories, persons and entities can be
found on the OFAC website at <http://www.treas.gov/ofac>.  In
addition, the programs administered by OFAC (the “OFAC Programs”)
prohibit dealing with individuals1 or entities in certain countries regardless of
whether such individuals or entities appear on the OFAC lists.

    

    4.16
Use of
Information. Any information which the undersigned has heretofore
furnished or furnishes herewith to the Company is complete and accurate and may
be relied upon by the Company in determining the availability of an exemption
from registration under Federal and state securities laws in connection with the
offering of Securities as described herein. The Purchaser further represents and
warrants that it will notify and supply corrective information to the Company
immediately upon the occurrence of any change therein occurring prior to the
Company's issuance of the Securities

    

    

    

      

    

      
      1 These individuals include
specially designated nationals, specially designated narcotics traffickers and
other parties subject to OFAC sanctions and embargo
programs.

    

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    ARTICLE
V

    

    COVENANTS OF THE
COMPANY

    

    5.1 Insurance. The
Company will maintain or cause to be maintained with financially sound and
reputable insurers, insurance with respect to its assets and business against
loss or damage covering risks of such types and in such amounts which are
customary for similarly situated corporations of established reputation engaged
in the same or similar businesses, in adequate amounts.

    

    5.2 Payment of Taxes and Other
Obligations. The Company will pay or cause to be paid all material taxes,
assessments and other governmental charges levied upon any of its assets or in
respect of its franchises, businesses, income or profits, all trade accounts
payable in accordance with usual and customary business terms, and all claims
for work, labor or materials, which if unpaid might become a Lien upon any asset
of the Company before the same become delinquent, except that (unless and until
foreclosure, restraint, sale or other similar proceedings shall have been
commenced) no such charge need be paid if being contested in good faith and by
appropriate measures promptly initiated and diligently conducted if (a) such
reserve or other appropriate provision, if any, as shall be required by sound
accounting practice consistent with GAAP shall have been made therefor, and (b)
such contest does not have a material adverse effect on the financial condition
of the Company or the ability of the Company to pay any Indebtedness and no
assets are in imminent danger of forfeiture.

    

    5.3 Compliance With Laws.
The Company will comply, and will cause each of its

    Subsidiaries
to comply, with all material laws (including, but not limited to, Environmental
Laws), rules, regulations, judgments, orders and decrees of any governmental or
regulatory authority applicable to its and their respective assets.

    

    5.4 Corporate Existence;
Property. The Company will preserve, protect and maintain (a) its
corporate existence, and (b) all rights, franchises, accreditations, privileges,
and properties, the failure of which to preserve, protect, and maintain might
have a material adverse effect on the business, affairs, assets, prospects,
operations, employee relations, rights or condition, financial or otherwise, of
the Company taken as a whole.

    

    5.5 Maintenance. The
Company will maintain and keep its properties in good repair, working order and
condition, subject to normal wear and tear, and from time to time make all
necessary repairs, renewals and replacements so that its businesses may be
properly and advantageously conducted at all times.

    

    5.6 Other Obligations.
The Company will comply with all obligations which it incurs pursuant to any
contract or agreement, whether oral or written, express or implied, as such
obligations become due to the extent to which the failure to so comply could be
expected to have a material adverse effect upon the business, affairs, assets,
prospects, operations, employee relations, rights or condition, financial or
otherwise, of the

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

    Company,
unless and to the extent that the same are being contested in good faith and by
appropriate proceedings and adequate reserves (as determined in accordance with
GAAP) have been established on its books with respect thereto.

    

    5.7 No Restrictions. The
Company will not enter into or become subject to any agreement or instrument,
which by its terms would (under any circumstances) restrict the

    Company’s
right to perform the provisions of this Agreement or the Related
Agreements.

    

    5.8 Public Disclosures.
The Company will not disclose the Purchaser’s name or identity as an investor in
the Company in any press release or other public announcement or in any document
or material filed with any governmental entity, without the prior written
consent of the Purchaser and Placement Agent, unless such disclosure is required
by applicable law or governmental or Commission regulations or by order of a
court of competent jurisdiction.

    

    5.9 No Violation. None of
the execution and delivery of this Agreement and any Related Agreements, the
consummation of the transactions provided for herein and therein or contemplated
hereby and thereby, the fulfillment by the Company of the terms hereof or
thereof, will (a) conflict with or result in a breach of any provision of the
Articles of Incorporation or By-Laws of the Company, (b) result in a default or
breach, give rise to any right of termination, cancellation or acceleration, or
require any consent or approval, under any of the terms, conditions or
provisions of any material stock, bond, mortgage, indenture, loan, factoring
arrangement, license, agreement, lease or other instrument or obligation to
which the Company is a party or by which it or any of its respective assets may
be bound or (c) to the knowledge of the Company, violate any material law
(including, but not limited to, any Environmental Law), judgment, order, writ,
injunction, decree, statute, rule or regulation of any court, administrative
agency, bureau, board, commission, office, authority, department or other
governmental entity applicable to the Company or any of its assets.

    

    5.10
Use of
Proceeds. The Company will use the proceeds from the sale of the Shares
as specified herein.

    

    5.11
Fees and
Expenses.

    

    (a) The
Company will bear all of its own expenses in connection with the preparation,
execution and negotiation of this Agreement and the Related Agreements, and the
transactions contemplated hereby and thereby. Additionally, company is
responsible for up to $3,500.00 for legal fees in this matter, Purchaser is
responsible for any fees above this amount.

    

                          (b)
It is the Company’s obligation to file appropriate federal and
state

    forms regarding this
Offering.

    

    
      	
               
      

            	
              5.12
      Non-Manipulative
      Practices. Company shall under no circumstances
    engage

            

    

    in any
activities that could be construed as price manipulation.

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

    ARTICLE
VI

    

    DEFINITIONS

    

    6.1 Definitions. In
addition to the capitalized terms defined elsewhere in this

    Agreement,
the following capitalized terms shall have the following meanings when used in
this Agreement:

    

    (a)
“Common Stock” means the shares of common stock, $.001 par value per share, of
the Company.

    

    (b)
“Environmental Laws” means all federal, state and local laws, ordinances and
rules of common law relating to environmental, safety, or health matters,
including those relating to fines, orders, injunctions, penalties, damages,
contribution, cost recovery compensation, losses, or injuries resulting from the
release or threatened release of Hazardous Substances and the generation, use,
storage, transportation, or disposal of Hazardous Substances in any manner
applicable to the Company or its assets, including the Comprehensive
Environmental Response, Compensation and Liability Act of 1980 (42 U.S.C. §§
9601 et seq.), the Hazardous Materials Transportation Act (49 U.S.C. §§ 1801 et
seq the Resource Conservation and Recovery Act of 1976 (42 U.S.C. §§6901 et
seq.), the Federal Water Pollution Control Act (33 U.S.C. §§ 1251 et seq.), the
Clean air  Act (42 U.S.C. §§ 7401 et seq.), the Toxic Substances
Control Act of 1976 (15 U.S.C. §§ 2601 et seq.), the Safe Drinking Water Act (42
U.S.C. §§ 300f- §§ 300j-11 et seq, the Occupational Safety and Health Act of
1970 (29 U.S.C. §§ 651 et seq.), and the Emergency Planning and Community
Right-to-Know Act (42 U.S.C. §§ 11001 et seq.), each as heretofore and hereafter
amended or supplemented, and any analogous present or future federal, state, or
local statutes, rules, and regulations promulgated thereunder or pursuant
thereto, and any other present or future law, ordinance, rule, regulation,
permit, order, or directive addressing environmental, safety or health issues,
of or by the federal government, any state or political subdivision thereof, or
any agency, court, or body of the federal government or any state or political
subdivision thereof.

    

    (c)
“Execution Documents” means this Agreement and the Subscription
Agreement.

    

    (d)
“GAAP” means United States generally accepted accounting principles,
consistently applied.

    

     (e)
“Indebtedness” of any Person means the principal of, premium, if any, and unpaid
interest on (a) indebtedness for borrowed money, (b) indebtedness guaranteed,
directly or indirectly, in any manner by such Person, or in effect guaranteed,
directly or indirectly, in any manner by such Person through an agreement,
contingent or otherwise, to supply funds to, or in any other manner invest in,
the debtor, or to purchase indebtedness, or to purchase and pay for property if
not delivered or pay for services if not performed, primarily for
the

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    purpose
of enabling the debtor to make payment of the indebtedness or to assure the
owners of the indebtedness against loss, (c) all indebtedness secured by any
mortgage, lien, pledge, charge or other encumbrance upon property owned by such
Person, even though such Person has not in any manner become liable for the
payment of such indebtedness, (d) all indebtedness of such Person created or
arising under any conditional sale, lease (intended primarily as a financing
device) or other title retention or security agreement with respect to property
acquired by such Person even though the rights and remedies of the seller,
lessor or lender under such agreement or lease in the event of default may be
limited to repossession or sale of such property, and (e) renewals, extensions
and refunding of any such indebtedness.

    

    (f)
“Lien” means any mortgage, deed of trust, lien, security interest, pledge,
lease, conditional sale contract, claim, charge, easement, right of way,
assessment, restriction and other encumbrance of every kind.

    

    (g)
“Person” means an individual, a partnership, a corporation, a limited liability
company, an association, a joint stock company, a trust, a joint venture, an
unincorporated organization or a governmental entity or any department, agency
or political subdivision thereof.

    

    (h)
“Placement Agent” means Westcap Securities, Inc., an NASD registered
broker/dealer.

    

    (i)
“Related Agreement” means the Subscription Agreement.

    

    (j)
“Securities Act” means the Securities Act of 1933, as amended.

    

    6.2 Rules of
Construction. The following provisions shall be applied wherever
appropriate herein:

    

    (a)
“herein,” ”hereby,” “hereunder,” ”hereof” and other equivalent words shall refer
to this Agreement as an entirety and not solely to the particular portion of
this Agreement in which any such word is used;

    

    (b) all
definitions set forth herein shall be deemed applicable whether the words
defined are used herein in the singular or the plural;

    

    (c)
wherever used herein, any pronoun or pronouns shall be deemed to include both
the singular and plural and to cover all genders;

    

    (d) all
accounting terms not specifically defined herein shall be construed in
accordance with GAAP;

    

    (e)
neither this Agreement nor any other agreement, document or instrument referred
to herein or executed and delivered in connection herewith

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

    shall be
construed against either party as the principal draftsperson hereof or
thereof;

    

    (f) all
references or citations in this Agreement to statutes or regulations
or

    statutory
or regulatory provisions shall generally be considered citations to such
statutes, regulations or provisions as in effect on the date hereof, except that
when the context otherwise requires, such references shall be considered
citations to such statutes, regulations or provisions as in effect from time to
time, including any successor statutes, regulations or provisions directly or
indirectly superseding such statutes, regulations or provisions;

    

    (g) any
references herein to a particular Section, Article, Exhibit or Schedule means a
Section or Article of, or an Exhibit or Schedule to, this Agreement unless
another agreement is specified; and

    

    (h) the
Exhibits and Schedules attached hereto are incorporated herein by reference and
shall be considered part of this Agreement.

    

    

    ARTICLE
VII

    

    MISCELLANEOUS

    

    7.1 Consent to Amendments;
Waivers. The provisions of this Agreement may be amended, and the Company
may take any action herein prohibited, or omit to perform any act herein
required to be performed by it, only if the Company has obtained the written
consent of a majority in interest of the Purchasers in the Offering, such
consent not to be unreasonably withheld, delayed or conditioned.  No
other course of dealing between the Company and any Purchaser or any delay in
exercising any rights hereunder or under any of the Related Agreements shall
operate as a waiver of any rights of any such Purchaser. If the Company pays any
consideration to any Person for such consent to any amendment, modification or
waiver hereunder or under any of the Related Agreements, the Company shall also
pay each Purchaser granting its consent equivalent consideration computed on a
pro rata basis. Any waiver, permit, consent or approval of any kind or character
on the part of any party of any provisions or conditions of this Agreement or
any Related Agreement must be made in writing and shall be effective only to the
extent specifically set forth in such writing.

    

    7.2 Representations and
Warranties: Indemnification.

    

    (a) All
representations and warranties contained herein or in any Related Agreement or
made in writing by any party in connection herewith or therewith will survive
the execution and delivery of this Agreement and any investigation made at any
time by or on behalf of the Purchasers.

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

    

    (b) The
Company will defend, indemnify and hold the Purchasers harmless from and against
any and all actions, suits, losses, damages, liabilities, claims, obligations
and expenses (including, but not limited to, legal fees and court costs)
(“Losses”), whether or not resulting from judgments or arbitration awards, that
shall be suffered or incurred by such Purchasers resulting from or arising out
of any breach of any of the representations, warranties or covenants of the
Company contained in this Agreement or in any Related Agreement or in any
schedule, certificate, exhibit or other instrument furnished or to be furnished
by the Company hereunder or thereunder.

    

    (c) Each
Purchaser will, jointly and severally, defend, indemnify and hold the Company
harmless from and against any and all losses, whether or not resulting from
judgment or arbitration awards, that shall be suffered or incurred by the
Company resulting from or arising out of any breach of any of the
representations, warranties or covenants of the Purchasers contained in this
Agreement or in any Related Agreement or in any schedule, certificate, exhibit
or other instrument furnished or to be furnished by the Purchasers hereunder or
thereunder.

    

    7.3 Successors and
Assigns. Except as otherwise expressly provided herein, all covenants and
agreements contained in this Agreement by or on behalf of any of the parties
hereto will bind and inure to the benefit of the respective successors and
assigns of the parties hereto, whether so expressed or not, provided, however,
that neither party shall assign (by operation of law or otherwise) this
Agreement or any part hereof or any obligation hereunder without the prior
written consent of the Company or the Purchaser. In addition, and whether or not
any express assignment has been made, the provisions of this Agreement which are
for the benefit of the Purchasers are also for the benefit of, and enforceable
by, any subsequent holders of all or any part of the Shares. The Shares may not
be transferred unless such transfer is registered under the Securities Act or
unless an exemption from such registration is available, which exemption shall
be established either by an opinion of counsel delivered by the holder of the
Shares being transferred or by other customary means.

    

    7.4 Descriptive Headings.
The descriptive headings of this Agreement are inserted for convenience of
reference only and do not constitute a part of and shall not be utilized in
interpreting this Agreement.

    

    7.5 Notices. Any notices
required or permitted to be sent hereunder shall be delivered personally or
mailed, by certified mail, return receipt requested, or delivered by overnight
courier service to the following addresses, or such other address as any party
hereto designates by written notice to the Company, and shall be deemed to have
been given upon delivery, if delivered personally, five days after mailing, if
mailed, or one business day after delivery to the courier, if delivered by
overnight courier service.

    

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    If to the
Company:

    

    GAMMA
PHARMACEUTICALS INC.

    7747 W.
Lake Mead Blvd.

    Las
Vegas, NV 89128-1026

    

    If to the Purchasers:

    Kenridge Holdings LLC

    2440 Northwest 26th
Circle

    Boca Raton, Fla 33431

    

    7.6 Governing Law. This
Agreement and the rights and duties of the parties hereto shall be governed by
the laws of the State of Nevada (without regard to principles of conflicts of
law).

    

    7.7 Execution in
Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an
original, and such counterparts together shall constitute one
instrument.

    

    7.8 Consent to
Jurisdiction. The Company and the Purchasers hereby irrevocably agree
that any suit, action, proceeding or claim against it arising out of or in any
way relating to this agreement or any of the related agreements, or any judgment
entered by any court in respect thereof, may be brought or enforced in the state
or federal courts located in Las Vegas, Nevada and hereby irrevocably waives, to
the fullest extent permitted by law, any objection which they may now or
hereafter have to the venue of any proceeding brought in said jurisdiction, and
further irrevocably waives any claims that any such proceeding has been brought
in an inconvenient forum.

    

    

    

    

    

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    

    SECURITIES
PURCHASE AGREEMENT - SIGNATURE PAGE

    

    The
parties hereto have executed this Securities Purchase Agreement as of the date
set

    forth
below.

    

    COMPANY:

    GAMMA
PHARMACEUTICALS INC.

    

     

    
      By:/s/Joseph
Cunningham                                                                           

      Joseph Cunningham, Director
on behalf of Gamma
Pharmaceuticals Inc.

    

    

    

    PURCHASER:

    

    

     By:
/s/Andres
Gomez-Mena                                                                           

            Andres Gomez-Mena, on behalf of Kenridge
LLC

    

    

    

    

    Date:
June 17, 2008

    
      
        
          -  -

        

         

      

      
        18ex10-14.htm

    
      
         

      

       

      
         

      

    

    LAW
OFFICES OF DAVID E. PRICE

    ESCROW
AGREEMENT

    

    A. This
Escrow Agreement (the “Agreement”) is made and entered into this June 17th, 2008,
by and among KENRIDGE HOLDING
LLC, a Florida entity, by Harold Sahlen, signing on it’s behalf, and
GAMMA PHARMACEUTICALS,
INC., a US publicly traded company and Delaware entity; and the Law
Offices of David Price, a law firm located at 13520 Oriental Street, Rockville,
Maryland 20853, which will act as Escrow Holder.

    

    WITNESSETH:

    

    B. Whereas,
KENRIDGE HOLDING LLC. is to wire unto this Escrow Agent $1,000,000.00 (One
Million) USD for purchase of shares in Gamma Pharmaceuticals, Inc.

    C. Whereas
Escrow shall hold said funds in fiduciary trust until such time as Gamma
Pharmaceuticals, Inc. shall furnish escrow with 1,333,333 (One Million Three
Hundred Thirty Three Thousand Three Hundred Thirty Three) common restricted
unencumbered shares. Additionally Warrants shall be issued in the following
categories & Strike Price; A, .75 each for 1,333,333; B $1.00 each for
1,333,333; and C, $1.25 for 1,333,333. All said Warrants shall have a five year
exercise right.

    D. Escrow
Agent hereby agrees to furnish the 144 Legal Opinion Letter to remove the
restrictive legend upon said shares as soon as the six month waiting period has
ended.

    E. Upon
receipt of said shares in their entirety, Escrow shall release the $1,000,000 to
Gamma.

    F.           Whereas,
Kenridge Holding LLC & Gamma Pharmaceuticals, Inc. have entered into a
certain SUBSCRIPTION PURCHASE AGREEMENT dated June 17, 2008; (the “Agreement”),
and incorporated herein by reference.

    G.           Whereas,
it is necessary to establish an escrow account for the Deposit of said shares
and further Fiduciary activities on behalf of the companies.

    

    

    NOW,
THEREFORE, in consideration of the mutual promises, covenants, and
representations contained herein, the receipt and sufficiency of which are
hereby acknowledged, THE PARTIES HERETO AGREE AS FOLLOWS:

    

    
      	 	
              1.           Pecuniary
      Consideration:    KENRIDGE HOLDING LLC shall
      make a one time cash infusion of $1,000,000,000 (One Million USD) to
      Escrow Agent who shall hold said funds for Gamma. Only upon receipt of all
      shares shall Escrow send the funds to
Gamma.

            

    

    2.           The
Warrants mentioned supra shall have the specified strike price: A, .75 each for
1,333,333; B $1.00 each for 1,333,333; and C, $1.25 for 1,333,333. All said
Warrants shall have a five year exercise right.

    

    3.           The
Escrow Holder shall have no duties or obligations other than those specifically
set forth herein.  The acceptance by the Escrow Holder of his duties
under this Escrow Agreement is subject to the terms and conditions hereof, which
shall govern and control with respect to his rights,

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    duties,
liabilities and immunities.

    

    4.           The
parties understand and agree that the Escrow Holder is not a principal,
participant or beneficiary of the underlying transactions that necessitate this
Escrow Agreement.  The Escrow Holder shall be obligated only for the
performance of such duties as are specifically set forth herein and may rely and
shall be protected in acting or refraining from acting on any instrument
believed by him to be genuine and to have been signed or presented by the proper
party or parties, their officers, representatives or agents.  So long
as the Escrow Holder has acted in good faith and has not been guilty of willful
misconduct or gross negligence, the Escrow Holder shall have no liability under,
or duty to inquire beyond the terms and provisions of, this Escrow Agreement,
and it is agreed that his duties are purely administrative in
nature.  The Escrow Holder shall, in no event, be liable for any
exemplary or consequential damages.

    

    5.           The
Escrow holder shall not be obligated to take any legal actions hereunder that
might, in the Escrow Holder’s judgment, involve any expense or liability, unless
the Escrow Holder shall have been furnished with reasonable
indemnity.

    

    6           The
Escrow Holder is not bound in any way by any other contract or agreement between
or among the parties hereto, whether or not the Escrow Holder has knowledge of
its terms or conditions, and the Escrow Holder’s only duty, liability and
responsibility shall be to hold and deal with the documents delivered to him as
herein directed.

    

    7.   The
Escrow Holder shall not be bound by any modification, amendment, termination,
cancellation, rescission or supersession of this Escrow Agreement unless the
same shall be in writing and signed by all of the other parties
hereto.

    

    8.           The
parties hereto agree, jointly and severally, to indemnify the Escrow Holder
against, and hold the Escrow Holder harmless from, anything that the Escrow
Holder may do or refrain from doing in connection with their performance or
non-performance as Escrow Holder under this Agreement and any and all losses,
costs, damages, expenses, claims and attorneys’ fees suffered or incurred by the
Escrow Holder as a result of, in connection with or arising from or out of the
acts or omissions of the Escrow Holder in the performance of or pursuant to this
Agreement, except such acts or omissions as may result from the Escrow Holder’s
willful misconduct or gross negligence.

    

    9.           In
the event of any disagreement between or among the KENRIDGE HOLDING LLC and GAMMA PHARMACEUTICAL
concerning this Escrow Agreement or between or among them or any of them
and any other person, resulting in adverse claims or demands being made in
connection with the funds, or in the event that the Escrow Holder is in doubt as
to what action the Escrow Holder should take hereunder, the Escrow Holder may,
at his option, refuse to comply with any claims or demands on him, or refuse to
take any other action hereunder, so long as such disagreement continues or such
doubt exists, and in any such event, the Escrow Holder shall not be or become
liable in any way or to any person for his failure or refusal to act, and the
Escrow Holder shall be entitled to continue so to refrain from acting until the
signing of a unified document by both original signors to this contract,
specifically requesting the Escrow Agent to undertake an act
certain.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    10.       Should
the Escrow Holder become involved in litigation in any manner whatsoever on
account of this Agreement, the funds, the stock certificates and/or otherwise,
the parties hereto (other than Escrow Holder) hereby bind and obligate
themselves, their heirs and their personal representatives, successors and
assigns to pay the Escrow Holder, in addition to any charge made hereunder for
acting as Escrow Holder, reasonable attorneys’ fees incurred by the Escrow
Holder and any other disbursements, expenses, losses, costs or damages in
connection with or resulting from such actions.

    

    11.      If
at any time a dispute shall exist as to the terms of this Agreement, the duties
of the Escrow Agent hereunder or the rights of any person in or to any or all of
the funds deposited in the Escrow Account, the Escrow Agent may deposit all
escrowed funds and documents, together with all documents delivered to them
pursuant to this Agreement, with the Clerk of a District Court in the State of
Maryland, and may interplead the parties hereto.  Upon so depositing
such escrowed funds and documents and filing their complaint in interpleader,
the Escrow Agent shall be completely discharged and released from all further
liability or responsibility under the terms of this Agreement. The parties
hereto, for themselves and their successors and assigns, do hereby submit
themselves to the jurisdiction of said Court and do hereby appoint the Clerk of
said Court as their agent for service of all process in connection with the
proceedings mentioned in this paragraph.

    

    12.           The
terms of these instructions are irrevocable by the undersigned unless such
revocation is consented to in writing by all three parties to this
contract.

    

    13.           Any
notices or other communications required or permitted hereunder shall be
sufficiently given if personally delivered to or sent by either e-mail,
registered or certified mail, postage prepaid, addressed as
follows:

    

    If to Kenridge
Holding:

    2440 NW
26th
Circle

    Boca
Raton, Florida 33431

    

    If to Gamma
Pharmaceuticals:

    77477 W.
Lake Mead Blvd.

    Suite
170

    Las
Vegas, NV 89128-1026

    

    If to the Escrow
Holder:

    David E.
Price, Esq.

    13520
Oriental St

    Rockville,
Md 20853

    (301)
460-5818

    David@TopTierStrategies.com

    

    or such other address as shall be
furnished in writing by any party in the manner for giving notices hereunder,
and any such notice or communication shall be deemed to have been given as of
the date so delivered, mailed or sent by facsimile.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    14.           This
Escrow Agreement shall be construed according to the laws of the State of
Maryland.  The parties submit themselves to the exclusive jurisdiction
of the Courts of the State of Maryland in the event of any dispute.

    

    15.           This
Escrow Agreement may be executed in any number of counterparts, each of which
shall be deemed to be an original and all of which taken together shall be
deemed to constitute one and the same.  Facsimile copies may act as
originals.

    

    16.           A
copy of the Selling Agreement signed by the parties has been attached to and
made a part of this Escrow Agreement.

    

    This
Escrow Agreement is executed as of June 17th,
2008

    

    

    /s/Harold
Sahlen

    Harold Sahlen on behalf of

    Kenridge
Holding LLC

    

    

    

    /s/Joseph
Cunningham

    Joseph Cunningham, on behalf of

    Gamma
Pharmaceuticals, Inc.

    

    

    

    /s/David
E. Price, Esq.

    David E. Price, Esq. Escrow
Agent.

    

    

    
      
         

      

      
        4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]